Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Nanosubs Gain Better Fluorescent Properties for Tracking

By Rice University | June 14, 2016

Rice University scientists have created light-driven, single-molecule submersibles. A new version of the molecule strengthens its fluorescent response for better tracking. Atoms in red make up the light-activated motor. Source: Tour Group/Rice University

The next generation of nanosubmarines being developed at Rice University has been upgraded with tags that fluoresce longer, which enables the submersibles to be tracked for greater periods while being driven through a solution.

The single-molecule vehicles introduced by the Rice lab of chemist James Tour last year may someday be used to deliver drugs or other cargo. The new version built and tested with collaborators at Tel Aviv University in Israel is the subject of a recent paper in the American Chemical Society journal Organic Letters.

The first nanosub, USN-1, could be monitored but not imaged by a technique that would irradiate it with light for very short times. But that did not offer information about the submersible’s trajectory, according to lead author Víctor García-Lopéz, a former Rice graduate student. The latest model, the 334-atom USN-2, can be viewed by single-molecule microscopy for at least 1.5 seconds, long enough for 30 frames of video.

“This makes it possible for us to track the trajectory of a single nanosubmersible,” Tour said. “It should lead to a better understanding of how our vehicles move.”

The lab attached cyclooctatetraene (COT) to the molecule’s body and motor to keep them from bleaching, which quenches fluorescence. The light-driven motor developed by scientists in the Netherlands is a tail-like ligand that spins about a million times per second. The new subs, like the originals, are capable of moving 15 meters per second over nanoscale distances, based on the thrust provided by each turn of the rotating motor. Between the frequent collisions that stop their forward motion, Tour said, they are “the fastest-moving molecules ever seen in solution.”

The nanosubmarines still can’t be steered in the traditional sense, Tour said. The team is satisfied for the moment with achieving “enhanced diffusion” that lets them figure out how to move a one-molecule vehicle in a solution of similarly sized molecules.

“The next step is to track these nanosubmarines in solution and see if we can use them to deliver cargo or interact with cells,” Tour said.


Filed Under: Drug Discovery

 

Related Articles Read More >

Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE